All Stories

  1. Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer
  2. The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studies
  3. Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera
  4. Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer
  5. Global proteomic characterization of microdissected estrogen receptor positive breast tumors
  6. 4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer
  7. Antibody-Based Capture of Target Peptides in Multiple Reaction Monitoring Experiments
  8. Ferritin Heavy Chain in Triple Negative Breast Cancer: A Favorable Prognostic Marker that Relates to a Cluster of Differentiation 8 Positive (CD8+) Effector T-cell Response
  9. Comparative Proteome Analysis Revealing an 11-Protein Signature for Aggressive Triple-Negative Breast Cancer
  10. Quantitative Proteomic Analysis of Microdissected Breast Cancer Tissues: Comparison of Label-Free and SILAC-based Quantification with Shotgun, Directed, and Targeted MS Approaches